Part D Claims Data Sharing: Lack Of Progress Gets MedPAC’s Attention
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicare advisory panel is considering a recommendation for congressional action to spur availability of Medicare drug data for policy and safety research.
You may also be interested in...
2009 Medicare Budget Plan Pushes For ESA Bundling With Dialysis Rates
Single-payment proposal comes with no details on how the system would function.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.